NEW YORK (Reuters Health) – In smokers and former smokers, annual lung cancer screening with low-dose (LD) CT scans should not be discontinued after a negative result, according…
NEW YORK (Reuters Health) – The incidence of breast cancer in women prescribed testosterone implant treatment for symptoms of androgen deficiency is lower than in several comparison groups,…
NEW YORK (Reuters Health) – A multinational study has shown that progression-free survival in elderly patients with untreated metastatic colorectal cancer (CRC) is improved significantly when bevacizumab is…
NEW YORK (Reuters Health) – Elderly patients with unresected stage III non-small-cell lung cancer (NSCLC) who are not candidates for chemoradiotherapy benefit from radiation therapy (RT) alone, according…
NEW YORK (Reuters Health) – After resection of pancreatic adenocarcinoma, chemotherapy with fluorouracil or gemcitabine reduces mortality by about a third, Taiwanese researchers have shown. On the other…
NEW YORK (Reuters Health) – Impaired kidney function related to treatment of childhood cancer does not recover over time, according to a Dutch study reported in Cancer Epidemiology,…
By Will Boggs, MD NEW YORK (Reuters Health) – Port-A-Cath-related thrombosis develops in up to 40% of pediatric oncology patients, researchers from Switzerland report. “Children with cancer who…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
NEW YORK (Reuters Health) – After primary surgery for early-stage endometrial cancer, adjuvant external beam radiation therapy confers no survival benefit overall, according to a Norwegian study. In…
NEW YORK (Reuters Health) – Among several different DNA-based quantitative polymerase chain reaction (qPCR) assays for detecting a critical JAK2 mutation in myeloproliferative neoplasms, one stands out as…